• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苯硼酸接枝壳聚糖作为一种葡萄糖敏感的载体用于控制胰岛素释放。

Phenylboronic acid grafted chitosan as a glucose-sensitive vehicle for controlled insulin release.

机构信息

Key Laboratory of Hormones and Development Ministry of Health, Metabolic Diseases Hospital, Tianjin Medical University, Tianjin 300070, China.

出版信息

J Pharm Sci. 2011 Jun;100(6):2278-86. doi: 10.1002/jps.22463. Epub 2011 Jan 25.

DOI:10.1002/jps.22463
PMID:21268025
Abstract

To develop self-regulated insulin delivery system, the glucose-sensitive copolymers with a fraction of phenylboronic acid group were prepared by the coupling reaction of -COOH of N-(carboxyacyl) chitosan and -NH(2) of 3-aminophenylboronic acid. A sufficient glucose sensitivity of the copolymer was accomplished by the glucose-induced volume changes of the nanoparticles and release profiles of insulin in phosphate buffered saline (PBS, pH 7.4) with different glucose concentrations, which occurred in a remarkable glucose concentration-dependent manner. Furthermore, circular dichroism spectroscopy demonstrates that the overall tertiary structure of the released insulin was not altered compared with that of the standard insulin. The analysis of relative cell proliferation suggests that the copolymer showed good cytocompatibility. The glucose-sensitive copolymers have a potential use in self-regulated drug-releasing systems.

摘要

为了开发自我调节的胰岛素输送系统,通过 N-(羧基酰基)壳聚糖的-COOH 和 3-氨基苯硼酸的-NH2 的偶联反应,制备了具有部分苯硼酸基团的葡萄糖敏感共聚物。通过纳米粒子的葡萄糖诱导的体积变化和在不同葡萄糖浓度的磷酸盐缓冲盐水(PBS,pH7.4)中的胰岛素释放曲线,实现了共聚物的充分葡萄糖敏感性,其显著地依赖于葡萄糖浓度。此外,圆二色性光谱表明,与标准胰岛素相比,释放的胰岛素的整体三级结构没有改变。相对细胞增殖的分析表明,共聚物具有良好的细胞相容性。葡萄糖敏感共聚物在自我调节药物释放系统中有潜在的应用。

相似文献

1
Phenylboronic acid grafted chitosan as a glucose-sensitive vehicle for controlled insulin release.苯硼酸接枝壳聚糖作为一种葡萄糖敏感的载体用于控制胰岛素释放。
J Pharm Sci. 2011 Jun;100(6):2278-86. doi: 10.1002/jps.22463. Epub 2011 Jan 25.
2
Development of shell cross-linked nanoparticles based on boronic acid-related reactions for self-regulated insulin delivery.基于硼酸相关反应的壳交联纳米颗粒用于自我调节胰岛素递送的研究进展
J Biomater Sci Polym Ed. 2017 Jan;28(1):93-106. doi: 10.1080/09205063.2016.1246289. Epub 2016 Oct 21.
3
Amphiphilic random glycopolymer based on phenylboronic acid: synthesis, characterization, and potential as glucose-sensitive matrix.基于苯硼酸的两亲性无规糖聚合物:合成、表征及作为葡萄糖敏感基质的潜力
Biomacromolecules. 2009 Jun 8;10(6):1337-45. doi: 10.1021/bm8010006.
4
Preparation of N,O-carboxymethyl chitosan nanoparticles as an insulin carrier.制备 N,O-羧甲基壳聚糖纳米粒作为胰岛素载体。
Drug Deliv. 2009 Nov;16(8):458-64. doi: 10.3109/10717540903353090.
5
Phenylboronic acid as a glucose-responsive trigger to tune the insulin release of glycopolymer nanoparticles.苯硼酸作为一种葡萄糖响应触发剂来调节糖聚合物纳米颗粒的胰岛素释放。
J Biomater Sci Polym Ed. 2016;27(7):599-610. doi: 10.1080/09205063.2016.1140503. Epub 2016 Mar 9.
6
Preparation, characterization, and oral delivery of insulin loaded carboxylated chitosan grafted poly(methyl methacrylate) nanoparticles.负载胰岛素的羧化壳聚糖接枝聚甲基丙烯酸甲酯纳米颗粒的制备、表征及口服给药
Biomacromolecules. 2009 May 11;10(5):1253-8. doi: 10.1021/bm900035u.
7
Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin.海藻酸钠-壳聚糖微球的制备及其用于胰岛素口服给药的评价。
Eur J Pharm Biopharm. 2011 Jan;77(1):11-9. doi: 10.1016/j.ejpb.2010.09.016. Epub 2010 Oct 7.
8
Probing insulin's secondary structure after entrapment into alginate/chitosan nanoparticles.胰岛素包封于海藻酸盐/壳聚糖纳米颗粒后的二级结构探究
Eur J Pharm Biopharm. 2007 Jan;65(1):10-7. doi: 10.1016/j.ejpb.2006.09.005. Epub 2006 Sep 24.
9
Glucose-responsive vehicles containing phenylborate ester for controlled insulin release at neutral pH.含苯硼酸酯的葡萄糖响应型载体用于在中性 pH 下控制胰岛素释放。
Biomacromolecules. 2012 Jun 11;13(6):1837-44. doi: 10.1021/bm3003286. Epub 2012 May 11.
10
Microcapsules of alginate/chitosan containing magnetic nanoparticles for controlled release of insulin.含磁性纳米粒子的海藻酸钠/壳聚糖微胶囊用于胰岛素的控制释放。
Colloids Surf B Biointerfaces. 2010 Nov 1;81(1):206-11. doi: 10.1016/j.colsurfb.2010.07.008. Epub 2010 Jul 14.

引用本文的文献

1
Dissolving Microneedle Patch Incorporated with Insulin Nanoparticles for The Management of Type-I Diabetes Mellitus: Formulation Development and in Vivo Monitoring.用于治疗I型糖尿病的含胰岛素纳米颗粒的溶蚀性微针贴剂:制剂开发与体内监测
Adv Pharm Bull. 2025 Jun 10;15(2):359-370. doi: 10.34172/apb.025.42583. eCollection 2025 Jul.
2
Phenylboronic Acid-Grafted Chitosan Nanocapsules for Effective Delivery and Controllable Release of Natural Antioxidants: Olive Oil and Hydroxytyrosol.用于天然抗氧化剂(橄榄油和羟基酪醇)有效递送与可控释放的苯基硼酸接枝壳聚糖纳米胶囊
Pharmaceutics. 2022 Dec 27;15(1):81. doi: 10.3390/pharmaceutics15010081.
3
Dual-sensitive chitosan derivative micelles for site-specific drug release in the treatment of chicken coccidiosis.
用于鸡球虫病治疗中实现药物定点释放的双敏感壳聚糖衍生物胶束
RSC Adv. 2018 Apr 17;8(26):14515-14526. doi: 10.1039/c8ra02144a.
4
Recent Applications of Dual-Stimuli Responsive Chitosan Hydrogel Nanocomposites as Drug Delivery Tools.近期应用双刺激响应壳聚糖水凝胶纳米复合材料作为药物传递工具。
Molecules. 2021 Aug 5;26(16):4735. doi: 10.3390/molecules26164735.
5
Progress in the Development of Chitosan Based Insulin Delivery Systems: A Systematic Literature Review.基于壳聚糖的胰岛素递送系统的发展进展:一项系统的文献综述。
Polymers (Basel). 2020 Oct 27;12(11):2499. doi: 10.3390/polym12112499.
6
Boronic Acid as Glucose-Sensitive Agent Regulates Drug Delivery for Diabetes Treatment.硼酸作为葡萄糖敏感剂调节药物递送用于糖尿病治疗。
Materials (Basel). 2017 Feb 13;10(2):170. doi: 10.3390/ma10020170.
7
Cross-Linked Dependency of Boronic Acid-Conjugated Chitosan Nanoparticles by Diols for Sustained Insulin Release.二醇介导的硼酸共轭壳聚糖纳米颗粒的交联依赖性用于胰岛素的持续释放
Pharmaceutics. 2016 Oct 8;8(4):30. doi: 10.3390/pharmaceutics8040030.
8
Correlating physicochemical properties of boronic Acid-chitosan conjugates to glucose adsorption sensitivity.将硼酸-壳聚糖缀合物的物理化学性质与葡萄糖吸附灵敏度相关联。
Pharmaceutics. 2012 Dec 27;5(1):69-80. doi: 10.3390/pharmaceutics5010069.